Track topics on Twitter Track topics that are important to you
In Bristol/Pfizer's ARISTOPHANES real-world study, the rate of major bleeding with Eliquis was 46% lower than J&J/Bayer's Xarelto and 33%...
Delivery of the Report will take 23 working days once order is placed.The Global Thrombus Management Equipment Market Research Report Forecast 20172022 is a valuable source of insightful data for busi...
Delivery of the Report will take 23 working days once order is placed.The Global Thrombus Precursor Protein Market Research Report Forecast 20172022 is a valuable source of insightful data for busines...
Eliquis and Opdivo sales drive growth in the quarter
US pharma major Bristol-Myers Squibb was on its way up in pre-market trading on Monday after reporting…
Findings have been released from the largest real-world data (RWD) analysis of non-valvular atrial fibrillation…
Eliquis, the pharmas' blood thinner, is now a blockbuster. Yet the companies see growth ahead, tapping real-world data to convince doctors and payers of its benefit.
Thrombus perviousness has been associated with favorable functional outcome in acute ischemic stroke (AIS) patients. Measuring thrombus perviousness on CTA may be suboptimal due to potential delay in ...
Atherosclerotic plaque rupture or erosion and subsequent development of platelet-containing thrombus formation is the fundamental cause of cardiovascular disease, which is the most common cause of dea...
Among patients undergoing cardioversion for atrial fibrillation, the presence of left ventricular thrombus is a relatively uncommon and challenging clinical dilemma. While left atrial appendage thromb...
Blood-contacting devices have contributed to improving the treatment of patients. However, thrombus formation at the interface between a connector and tube is still a potential source of thrombus-rela...
To characterize the presence of bland (non-tumor) thrombus in advanced renal cell carcinoma and assess the impact of this finding on cancer-specific survival.